Vanguard Investments Australia
CLB icon

Vanguard Investments Australia’s Core Laboratories CLB Stock Holding History

Vanguard Investments Australia’s Portfolio CLB Stock Details CLB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$118K Hold
10,100
– – ﹤0.01% 2285
2026
Q1 		$170K Buy
+10,100
New +$181K ﹤0.01% 2112

Other funds holding CLB

AI
Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
DGI
Disciplined Growth Investors Minneapolis, Minnesota $5.91B AUM 53.97% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $27.7B AUM 52.44% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
CAMG
CWA Asset Management Group Naples, Florida $3.28B AUM 34.07% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Schroder Investment Management Group
Schroder Investment Management Group London, United Kingdom $141B AUM 34.18% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Investments Australia's CLB Position: Q2 2026 in Review

Vanguard Investments Australia held its Core Laboratories (CLB) position steady in Q2 2026 at 10,100 shares worth $118K. The position accounts for ﹤0.01% of the portfolio, ranked #2285.

Vanguard Investments Australia first reported a position in CLB in Q1 2026 and has held it in 2 quarters since. The position peaked at $170K in Q1 2026. 179 funds tracked by Wall St. Rank hold CLB as of Q2 2026.

  • Vanguard Investments Australia held 10,100 shares of Core Laboratories worth $118K as of Q2 2026.
  • Vanguard Investments Australia left its Core Laboratories share count unchanged in Q2 2026.
  • Core Laboratories made up ﹤0.01% of Vanguard Investments Australia's portfolio in Q2 2026, its #2285 holding.
  • Vanguard Investments Australia first reported a position in Core Laboratories in Q1 2026 and has held it in 2 quarters since.
  • Vanguard Investments Australia's Core Laboratories position peaked at $170K in Q1 2026.
  • 179 funds tracked by Wall St. Rank held Core Laboratories as of Q2 2026.

Based on Vanguard Investments Australia's 13F filing for Q2 2026, filed 13 Aug 2026.